Indy Hematology Review

http://www.indyhematologyreview.com/

 

Brentuximab Vedotin for Previously Untreated Peripheral T-cell Lymphpoma (ECHELON-2 trial) - New Standard of Care & Mantle Cell Lymphoma - Treatment and Review of Current Trials

229 views
June 7, 2019
0 Comments
Login to view comments. Click here to Login
Indy Hematology Review 2019 Conference